Multidisciplinary Association for Psychedelic Studies

The Multidisciplinary Association for Psychedelic Studies (MAPS) has achieved FDA approval for its Phase 2 clinical trial, MJP2, after three years of negotiations and regulatory hurdles. This study will investigate the use of smoked cannabis in treating PTSD among 320 veterans across multiple states, aiming to generate real-world safety data. Funded by the Michigan Veteran […]